These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 4146992

  • 21. The effects of propranolol on cardiac conduction.
    Berkowitz WD, Wit AL, Lau SH, Steiner C, Damato AN.
    Circulation; 1969 Dec; 40(6):855-62. PubMed ID: 5387361
    [No Abstract] [Full Text] [Related]

  • 22. Local anaesthetic and anti-arrhythmic actions of alprenolol relative to its effect on intracellular potentials and other properties of isolated cardiac muscle.
    Singh BN, Williams EM.
    Br J Pharmacol; 1970 Apr; 38(4):749-57. PubMed ID: 4392560
    [Abstract] [Full Text] [Related]

  • 23. Effects of propranolol and alprenolol on intra-atrial conduction in the dog.
    Lhoste F, Giudicelli JF, Boissier JR.
    Eur J Pharmacol; 1974 Nov; 29(1):15-21. PubMed ID: 4435035
    [No Abstract] [Full Text] [Related]

  • 24. [The effect of Tobanum on human cardioelectrophysiology].
    Borbola J, Elkefarna A, Török E.
    Orv Hetil; 1980 Aug 31; 121(35):2129-32. PubMed ID: 6110201
    [No Abstract] [Full Text] [Related]

  • 25. Effects of synthetic oxytocin on cardiac arrhythmias induced in dogs by pentylenetetrazol, picrotoxin or deslanoside.
    Bircher RP, Tseng DT, Wang SC.
    Arch Int Pharmacodyn Ther; 1968 Mar 31; 172(1):37-48. PubMed ID: 5650332
    [No Abstract] [Full Text] [Related]

  • 26. [Arrhythmias. 7. Treatment with beta-receptor blocking agents].
    Johnsson G, Persson S.
    Lakartidningen; 1971 Jun 14; 68():Suppl II:100-. PubMed ID: 4398809
    [No Abstract] [Full Text] [Related]

  • 27. Effects of cedilanid-D and alprenolol in angina pectoris.
    Ekelund LG, Johnsson G, Melcher A, Orö L.
    Eur J Clin Pharmacol; 1973 Aug 14; 6(2):113-8. PubMed ID: 4769694
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Combined use of digitalis and propranolol HCl.
    Dreifus LS.
    Am Fam Physician; 1974 Jan 14; 9(1):178-81. PubMed ID: 4809762
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
    Singh BN.
    N Z Med J; 1973 Dec 26; 78(505):529-35. PubMed ID: 4150209
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The effect of D- and L-alprenolol on the isolated rat heart.
    Brus R, Drzewiecki J.
    Pol J Pharmacol Pharm; 1973 Dec 26; 25(5):429-34. PubMed ID: 4777346
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Anti-arrhythmic actions of -adrenergic receptor antagonists: review of fundamental aspects.
    Singh BN.
    N Z Med J; 1972 Nov 26; 76(486):333-42. PubMed ID: 4405558
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.
    Collste P, Haglund K, Frisk-Holmberg M, Rawlins MD.
    Eur J Clin Pharmacol; 1976 Jun 15; 10(2):85-8. PubMed ID: 9292
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.